AzTrials
AzTrials

InfluenzaNCT00798421

Study to Evaluate Nosocomial Transmission of Influenza

An observational study of Influenza, run by University Hospitals, Leicester at 1 site in United Kingdom.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The purpose of this study is to investigate whether influenza can be reliably transmitted from children to susceptible contacts in a health care setting. The goal is to develop a transmission that can then be used to assess interventions to prevent transmission Research objectives: To develop a model to investigate… Read more about this study

Who is it for?
Ages 18 to 40 yearsHealthy volunteers can take part
Conditions the study is for
Influenza
How many people
50 participants
Where
1 siteUnited Kingdom
Study dates
Dec 2008to May 2009
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 40 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Study population: 1. Healthy subject volunteers > 18 years of age 2. Children with confirmed influenza presenting to the Children's Hospital, Leicester Royal Infirmary

Who may be able to join

  • Infected Children
  • Age < 16 years
  • Parents or legal guardians willing to give informed written consent
  • Presenting with a febrile illness confirmed as influenza by near patient rapid antigen testing
  • Healthy volunteers
  • Willing to give informed written consent

Who cannot join

  • Children
  • No parents or legal guardians able to give informed consent
  • Healthy volunteers
  • known allergy to oseltamivir or zanamivir
  • presence of underlying condition or concomitant therapy requiring dose alteration of oseltamivir (severe renal or hepatic failure; methotrexate and probenecid)
  • underlying immunosuppressive disorder
Show all 12Show fewer
  • known galactose intolerance
  • underlying chronic medical condition known to increase risk of influenza-related complications (including asthma, chronic pulmonary airways disease, chronic cardiovascular disease, diabetes mellitus, chronic neurological disorder)
  • inability or contraindication to collection of nasal swabs
  • previous influenza vaccination within 2 years
  • current smoker
  • pregnancy

Trial locations and contacts

1 site in 1 country.

United Kingdom1 site
  • University Hospitals Leicester

    Leicester, Leics, LE1 5WW

    Iain Stephenson, FRCP, +44 116 2586952, iain.stephenson@uhl-tr.nhs.uk

Other trials in United Kingdom

About this study

Official title: Pilot Study to Develop a Model to Evaluate Nosocomial Transmission of Influenza

The purpose of this study is to investigate whether influenza can be reliably transmitted from children to susceptible contacts in a health care setting. The goal is to develop a transmission that can then be used to assess interventions to prevent transmission

Research objectives:

To develop a model to investigate the frequency of influenza transmission from an infected child to a susceptible health care worker

Research Hypotheses:

Influenza viruses can be transmitted from infected children to exposed health care workers

Read the detailed description

CHildren with influenza infection presenting to ED will be identified by RAT. Healthy healthcare worker subjects will expose themselves and perform specific activities with the child.

subjects will be followed by diary card, clinical symptom scores and virology swabs to assess frequency of transmission

Conditions
Influenza
Keywords
Influenza, transmission
Medical subject headings
Influenza, Human

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT00798421
Study groupRoleWhat they receive
Heathcare workerhealth care worker exposed to patient with influenza

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Frequency of transmission of influenza

    Measured: 1 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Nov 2008 (estimated)
  2. Study startDec 2008
  3. Primary completionApr 2009 (estimated)
  4. Study completionMay 2009 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
50 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00798421
Sponsor's protocol ID
UHL10421
Other IDs
REC 07/H0402/59
Status last verified
Nov 2008
First submitted
25 Nov 2008
Last updated
26 Nov 2008
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

An observational study of Influenza, run by University Hospitals, Leicester at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 26 Nov 2008. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Iain Stephenson, FRCP (+44 116 258 6952, iain.stephenson@uhl-tr.nhs.uk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Frequency of transmission of influenza (time frame: 1 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Nov 2008.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in